Wordt geladen...
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
Tofacitinib is an oral, Janus kinase (JAK) molecule, which selectively inhibits Janus-associated tyrosine kinases JAK1 and JAK3. It has already shown efficacy in the treatment of rheumatoid arthritis and the prevention of organ allograft rejection in kidney transplantation. Two separate phase III pl...
Bewaard in:
| Gepubliceerd in: | Frontline Gastroenterol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873536/ https://ncbi.nlm.nih.gov/pubmed/33613945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2020-101502 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|